RIGI and infection: Furthermore, VP56 degrades RIG-I via a K48-linked ubiquitination-mediated proteasomal pathway to inhibit RIG-I-regulated IFN antiviral responses, resulting in GCRV replication and infection enhancement and viral evasion.